Skip to main content

Emerging trends in AI in neuro-oncology

Explore the evolving role of artificial intelligence in neuro-oncology, and discover its potential to enhance diagnostic accuracy, predict patient outcomes, optimize treatment planning, and streamline clinical workflows.

Read more

Editor's Choice

Pancreatic cancer screening in people with diabetes

Explore biomarker screening approaches to identifying pancreatic ductal adenocarcinoma in people with diabetes, screening in high-risk groups, and practical strategies for early identification and monitoring.

Survival benefit of exercise in colon cancer rivals that of some drugs

Participation in a structured exercise program after adjuvant chemotherapy for colon cancer was associated with a significant survival benefit in the CHALLENGE trial.

Coronary angiogenesis in SCLC

  • Open Access
  • SCLC
  • Case Study

Small-cell lung cancer (SCLC) can show extensive angiogenesis, but direct arterial feeders arising from coronary vessels are exceedingly rare. We report a case where the left circumflex artery perfusing the tumor was successfully treated with coil embolization.

What's new in Merkel cell carcinoma

Merkel cell carcinoma is a rare, aggressive cutaneous neuroendocrine carcinoma. Learn about the diagnostic workup, prognostic markers, current treatments, and emerging targets.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more
SPONSORED

Masterclass webinar: Expert review of CAR-T cell therapy patient cases in R/R DLBCL or R/R FL

  • Live
  • Webinar | 29-07-2025 | 09:00 (CEST)

Professor Joy Ho leads a panel of Asia-Pacific-based experts, exchanging their practical experiences of identifying appropriate patients for CAR T-cell therapy, aspects of pre- and post-infusion management, and treatment sequencing, and sharing insights into optimizing outcomes in R/R DLBCL or R/R FL. 

This educational activity is intended for an audience of non-US, non-UK and on-label Asia Pacific healthcare professionals.

Watch it live: Tuesday 29th July, 09:00-10:30 (CEST)

Sponsored by:
  • Novartis Pharma AG
Prof. P. Joy Ho
Dr. Kentaro Fukushima
Prof. William Hwang
Prof. Dok Hyun Yoon
Prof. Miki Ando
Developed by: Springer Health+
Join the webinar
Webinar

Case Studies

Coronary angiogenesis in SCLC

  • Open Access
  • SCLC
  • Case Study

Small-cell lung cancer (SCLC) can show extensive angiogenesis, but direct arterial feeders arising from coronary vessels are exceedingly rare. We report a case where the left circumflex artery perfusing the tumor was successfully treated with coil embolization.

Concurrent hepatitis, cholangitis, and pancreatitis induced by an ICI

Imaging studies and liver biopsy led to a diagnosis of cholangitis, pancreatitis, and hepatitis as an immune-related adverse event in an older man undergoing treatment with pembrolizumab.

Synchronous HPV-associated squamous cell carcinoma and adenocarcinoma

A 54-year-old female tested HPV type 18 positive during a routine exam. Cervical liquid-based cytology showed ASCUS. Histopathology revealed HPV18-associated adenocarcinoma and squamous cell carcinoma at distinct cervical loci.

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Current Reviews

Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer

Discrete event simulation (DES) provides enhanced flexibility over modelling techniques that have been traditionally used for assessing health-economic outcomes, making it a particularly interesting technique for modelling complex clinical …

5-Aminolevulinic acid as an emerging radiosensitizer for radiodynamic therapy in solid tumors: a systematic review of available data and clinical potential

5‑Amniolevulinic acid (5-ALA) is an amino acid of the keto-carbon group. As a substrate in cellular heme synthesis, it is used to create porphobilinogen (PBG) in the mitochondrial matrix, which is then converted to protoporphyrin IX (PpIX) and …

Radiation Therapy for Abdominal or Pelvic Cancer Treatment in Patients with Inflammatory Bowel Disease: A Systematic Review

Inflammatory bowel disease (IBD) is a multisystem chronic inflammatory disorder, mainly affecting the gastrointestinal (GI) tract, as well as the hepatobiliary, musculoskeletal, ocular, and skin systems [ 1 ]. It includes two main entities, Crohn’s …

Circulating Biomarkers in Sarcoma

Soft tissue sarcoma (STS) is an uncommon malignancy comprising 1% of adult solid tumor [ 1 ]. There are over 100 histological subtypes of sarcoma, making it difficult to conduct subtype-specific analyses given the small incidence of each subtype.

At a glance: The DESTINY-Breast trials

The antibody–drug conjugate trastuzumab deruxtecan is being investigated in the DESTINY-Breast trials for the treatment of breast cancer.

Developed by: Springer Medicine
Read more

CME & eLearning

Vodcasts

Hear directly from experts in acute myeloid leukemia about innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
SPONSORED

Webinar

Professor Joy Ho and a panel of Asia-Pacific-based experts will examine real-life patient cases in this Masterclass, exchanging insights into their clinical experiences of using CAR T-cell therapy to treat patients with R/R DLBCL or R/R FL.

Please note, this educational activity is intended for an audience of non-US, non-UK and on-label Asia Pacific healthcare professionals.

Watch it live: Tuesday 29th July, 09:00-10:30 (CEST)

Sponsored by:
  • Novartis Pharma AG
Developed by: Springer Health+

Webinar

In this interactive webinar, experts discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations. 

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Developed by: Springer Health+

Further Reading

Phosphodiesterase 3 A expression in gastrointestinal stromal tumors

Phosphodiesterase 3A (PDE3A) is an emerging therapy target in various cancers with high expression, as in the majority of gastrointestinal stromal tumors (GISTs). However, its association with clinicopathological factors and patient survival in …

Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study

Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm …

Cytomegalovirus reactivation in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy has improved outcomes of relapsed and/or refractory large B-cell lymphoma (r/r LBCL). However, its off-tumor effects result in severe prolonged humoral immune deficiency. Cytomegalovirus (CMV) is a …

Predicting response to patients with gastric cancer via a dynamic-aware model with longitudinal liquid biopsy data

Gastric cancer (GC), which ranks fifth globally in prevalence, is the third leading cause of cancer-related mortality [ 1 , 2 ]. The widespread occurrence of GC demands the development of effective treatments and precise predictive models for …

Related topics

Ocular adverse effects of ADC arise from direct corneal infiltration

The antibody–drug conjugate belantamab mafodotin, used to treat relapsed or refractory multiple myeloma, enters the epithelium of the cornea primarily via limbal vessels, where it contributes directly to epithelial changes.

Read more

Emerging trends in AI in neuro-oncology

Explore the evolving role of artificial intelligence in neuro-oncology, and discover its potential to enhance diagnostic accuracy, predict patient outcomes, optimize treatment planning, and streamline clinical workflows.

Read more